Results 221 to 230 of about 26,474 (270)
Some of the next articles are maybe not open access.
Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index
Neurology, 2001The contribution of human T-cell lymphotropic virus (HTLV-I) DNA by PCR in CSF and the intrathecal synthesis of antibodies to HTLV-I by the antibody index (AI) to the diagnosis of HTLV-1-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) were evaluated. Cases of spastic paraparesis compatible with HAM/TSP had increased AI for HTLV-I (60/73)
M, Puccioni-Sohler +8 more
openaire +2 more sources
Journal of Neurology, 1996
The humoral immune response against human T-cell lymphotropic virus type I (HTLV-I) in the central nervous system (CNS) compartment and in the blood was investigated by enzyme immunoassay using 16 synthetic peptides corresponding to HTLV-I core and envelope sequences. We evaluated paired samples of cerebrospinal fluid and serum from HTLV-I seropositive
B, Kitze +9 more
openaire +2 more sources
The humoral immune response against human T-cell lymphotropic virus type I (HTLV-I) in the central nervous system (CNS) compartment and in the blood was investigated by enzyme immunoassay using 16 synthetic peptides corresponding to HTLV-I core and envelope sequences. We evaluated paired samples of cerebrospinal fluid and serum from HTLV-I seropositive
B, Kitze +9 more
openaire +2 more sources
Antibodies to HTLV‐I in populations of the southwestern Pacific
Journal of Medical Virology, 1988AbstractSera collected from 1,102 individuals in 14 populations of the southwestern Pacific between 1956 and 1979 were tested by ELISA for antibodies to human T‐cell leukemia virus type I (HTLV‐I). Selected sera were also tested by particle agglutination and immunoblotting.
David M. Asher +11 more
openaire +3 more sources
Antibodies to HTLV-I in Japanese Immigrants in Brazil
JAMA: The Journal of the American Medical Association, 1986To the Editor.— Human T-cell lymphotropic virus type I (HTLV-I), the causative agent of adult T-cell leukemia, is endemic in southern Japan, 1 the Caribbean islands, 2 and parts of Africa. 3 The prevalence of antibodies to HTLV-I is highest in Okinawa, Japan, where up to 31% of adults are seropositive in some regions. 4 Moreover, a high seroprevalence
T, Kitagawa +4 more
openaire +3 more sources
Adult T-Cell Leukemia with Anti-HTLV-I Antibody but No HTLV-I DNA in Tumor Cells
Acta Haematologica, 2001Adult T-cell leukemia (ATL) is usually defined as a malignant disease of T cells infected by human T-lymphotropic virus type I (HTLV-I). In the present study, we describe a 49-year-old woman with an acute type ATL, whose leukemic cells do not contain the HTLV-I genome. Laboratory tests revealed an increase in abnormal lymphocytes with convoluted nuclei,
H, Fujiwara +6 more
openaire +2 more sources
Human T-Cell Leukemia Virus (HTLV-I) Antibodies in Africa
Science, 1984Antibodies specific for human T-cell leukemia-lymphoma virus type I (HTLV-I) were demonstrated in serum samples from various groups of people in South Africa, Uganda, Ghana, Nigeria, Tunisia, and Egypt. The samples had been collected for other purposes and were presumably selected without bias toward clinical conditions associated with HTLV infections.
W. Saxinger +16 more
openaire +2 more sources
High seroprevalence of anti–HTLV‐I antibody in rheumatoid arthritis
Arthritis & Rheumatism, 1996AbstractObjective. To investigate the association between human T lymphotropic virus type I (HTLV‐I) infection and rheumatoid arthritis (RA) in Nagasaki, an area highly endemic for HTLV‐I infection.Methods. Sera from 113 female patients with RA and 19,796 female blood donors were screened for anti–HTLV‐I antibodies with a gelatin particle agglutination
K, Eguchi +5 more
openaire +2 more sources
[HTLV-I antibody screening of blood donors].
Beitrage zur Infusionstherapie = Contributions to infusion therapy, 1992Routine screening of 344,266 blood donations of approximately 200,000 donors for anti-HTLV-I was done by enzyme immuno assay (EIA). Repeatedly reactive samples were confirmed by Western Blot (WB) and radio immuno precipitation assay (RIPA). The prevalence of anti-HTLV-I in Bavarian blood donors is 0.02-0.026%. The specificity of HTLV-I-EIA is 99.95%.
G, Schwarzfischer +5 more
openaire +1 more source
Monoclonal Antibodies Define a Cellular Antigen Involved in HTLV-I Infection
Hybridoma, 1998The exact mechanism by which the human T cell leukemia viruses (HTLV) infects target cells remains unclear; although some molecules have been identified to be important in viral infection and entry. To investigate these phenomena, we generated a panel of monoclonal antibodies (MAb) against a B cell line (BJAB-WH) which is highly permissive for ...
M G, Agadjanyan +7 more
openaire +2 more sources
HTLV-I-SPECIFIC ANTIBODY IN AIDS PATIENTS AND OTHERS AT RISK
The Lancet, 1984Serum samples from 440 acquired immunodeficiency syndrome (AIDS) patients or individuals at risk for AIDS were examined by the enzyme-linked immunosorbent assay technique for antibodies to HTLV-I core proteins. Specific antibodies were detected in 7% of AIDS patients, 7% of patients with lymphadenopathy, 0% of healthy homosexual men, and 12% of healthy
Marjorie Robert-Guroff +15 more
openaire +2 more sources

